BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

314 related articles for article (PubMed ID: 34411838)

  • 1. MUC5B promoter variant rs35705950 and rheumatoid arthritis associated interstitial lung disease survival and progression.
    Juge PA; Solomon JJ; van Moorsel CHM; Garofoli R; Lee JS; Louis-Sydney F; Rojas-Serrano J; González-Pérez MI; Mejia M; Buendia-Roldán I; Falfán-Valencia R; Ambrocio-Ortiz E; Manali E; Papiris SA; Karageorgas T; Boumpas D; Antoniou KM; Sidiropoulos P; Trachalaki A; van der Vis JJ; Jamnitski A; Grutters JC; Kannengiesser C; Borie R; Kawano-Dourado L; Wemeau-Stervinou L; Flipo RM; Nunes H; Uzunhan Y; Valeyre D; Saidenberg-Kermanac'h N; Boissier MC; Richez C; Schaeverbeke T; Doyle T; Wolters PJ; Debray MP; Boileau C; Porcher R; Schwartz DA; Crestani B; Dieudé P
    Semin Arthritis Rheum; 2021 Oct; 51(5):996-1004. PubMed ID: 34411838
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MUC5B Promoter Variant and Rheumatoid Arthritis with Interstitial Lung Disease.
    Juge PA; Lee JS; Ebstein E; Furukawa H; Dobrinskikh E; Gazal S; Kannengiesser C; Ottaviani S; Oka S; Tohma S; Tsuchiya N; Rojas-Serrano J; González-Pérez MI; Mejía M; Buendía-Roldán I; Falfán-Valencia R; Ambrocio-Ortiz E; Manali E; Papiris SA; Karageorgas T; Boumpas D; Antoniou K; van Moorsel CHM; van der Vis J; de Man YA; Grutters JC; Wang Y; Borie R; Wemeau-Stervinou L; Wallaert B; Flipo RM; Nunes H; Valeyre D; Saidenberg-Kermanac'h N; Boissier MC; Marchand-Adam S; Frazier A; Richette P; Allanore Y; Sibilia J; Dromer C; Richez C; Schaeverbeke T; Lioté H; Thabut G; Nathan N; Amselem S; Soubrier M; Cottin V; Clément A; Deane K; Walts AD; Fingerlin T; Fischer A; Ryu JH; Matteson EL; Niewold TB; Assayag D; Gross A; Wolters P; Schwarz MI; Holers M; Solomon JJ; Doyle T; Rosas IO; Blauwendraat C; Nalls MA; Debray MP; Boileau C; Crestani B; Schwartz DA; Dieudé P
    N Engl J Med; 2018 Dec; 379(23):2209-2219. PubMed ID: 30345907
    [TBL] [Abstract][Full Text] [Related]  

  • 3.
    Joo YB; Ahn SM; Bang SY; Park Y; Hong SJ; Lee Y; Cho SK; Choi CB; Sung YK; Kim TH; Jun JB; Yoo DH; Bae SC; Lee HS
    RMD Open; 2022 Dec; 8(2):. PubMed ID: 36581384
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Associations of the MUC5B promoter variant with timing of interstitial lung disease and rheumatoid arthritis onset.
    McDermott G; Gill R; Gagne S; Byrne S; Huang W; Cui J; Prisco L; Zaccardelli A; Martin L; Kronzer VL; Moll M; Cho MH; Shadick N; Dellaripa PF; Doyle T; Sparks JA
    Rheumatology (Oxford); 2022 Nov; 61(12):4915-4923. PubMed ID: 35289841
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic role of MUC5B rs35705950 genotype in patients with idiopathic pulmonary fibrosis (IPF) on antifibrotic treatment.
    Biondini D; Cocconcelli E; Bernardinello N; Lorenzoni G; Rigobello C; Lococo S; Castelli G; Baraldo S; Cosio MG; Gregori D; Saetta M; Balestro E; Spagnolo P
    Respir Res; 2021 Apr; 22(1):98. PubMed ID: 33794872
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lifetime risk of rheumatoid arthritis-associated interstitial lung disease in
    Palomäki A; ; Palotie A; Koskela J; Eklund KK; Pirinen M; ; Ripatti S; Laitinen T; Mars N
    Ann Rheum Dis; 2021 Dec; 80(12):1530-1536. PubMed ID: 34344703
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of MUC5B gene on antisynthetase syndrome.
    López-Mejías R; Remuzgo-Martínez S; Genre F; Pulito-Cueto V; Rozas SMF; Llorca J; Fernández DI; Cuesta VMM; Ortego-Centeno N; Gómez NP; Mera-Varela A; Martínez-Barrio J; López-Longo FJ; Mijares V; Lera-Gómez L; Usetti MP; Laporta R; Pérez V; Gafas AP; González MAA; Calvo-Alén J; Romero-Bueno F; Sanchez-Pernaute O; Nuno L; Bonilla G; Balsa A; Hernández-González F; Grafia I; Prieto-González S; Narvaez J; Trallero-Araguas E; Selva-O'Callaghan A; Gualillo O; Castañeda S; Cavagna L; Cifrian JM; González-Gay MA
    Sci Rep; 2020 Jan; 10(1):1415. PubMed ID: 31996780
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Association Between MUC5B Mutations and Clinical Outcome in Patients with Rheumatoid Arthritis-Associated Interstitial Lung Disease: A Retrospective Exploratory Study in China.
    Wang N; Zhang Q; Jing X; Guo J; Huang H; Xu Z
    Med Sci Monit; 2020 Mar; 26():e920137. PubMed ID: 32142504
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The MUC5B Promoter Polymorphism is Not Associated With Non-ILD Chronic Respiratory Diseases or Post-transplant Outcome.
    Goos T; Verleden SE; De Sadeleer LJ; Van Herck A; Sacreas A; Vanstapel A; Kaes J; Geudens V; Aelbrecht C; Ruttens D; Lambrechts D; Vermeer S; Ceulemans LJ; Van Raemdonck DE; Godinas L; Yserbyt J; Vanaudenaerde BM; Verleden GM; Vos R; Wuyts WA
    Transpl Int; 2022; 35():10159. PubMed ID: 35651878
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Telomere length and genetic variant associations with interstitial lung disease progression and survival.
    Newton CA; Oldham JM; Ley B; Anand V; Adegunsoye A; Liu G; Batra K; Torrealba J; Kozlitina J; Glazer C; Strek ME; Wolters PJ; Noth I; Garcia CK
    Eur Respir J; 2019 Apr; 53(4):. PubMed ID: 30635297
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interaction between the promoter
    Stock CJ; Conti C; Montero-Fernandez Á; Caramori G; Molyneaux PL; George PM; Kokosi M; Kouranos V; Maher TM; Chua F; Rice A; Denton CP; Nicholson AG; Wells A; Sestini P; Renzoni EA
    Thorax; 2020 Oct; 75(10):901-903. PubMed ID: 32580994
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MUC5B rs35705950 minor allele associates with older age and better survival in idiopathic pulmonary fibrosis.
    van der Vis JJ; Prasse A; Renzoni EA; Stock CJW; Caliskan C; Maher TM; Bonella F; Borie R; Crestani B; Petrek M; Wuyts WA; Wind AE; Molyneaux PL; Grutters JC; van Moorsel CHM
    Respirology; 2023 May; 28(5):455-464. PubMed ID: 36571111
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Risk Score to Detect Subclinical Rheumatoid Arthritis-Associated Interstitial Lung Disease.
    Juge PA; Granger B; Debray MP; Ebstein E; Louis-Sidney F; Kedra J; Doyle TJ; Borie R; Constantin A; Combe B; Flipo RM; Mariette X; Vittecoq O; Saraux A; Carvajal-Alegria G; Sibilia J; Berenbaum F; Kannengiesser C; Boileau C; Sparks JA; Crestani B; Fautrel B; Dieudé P
    Arthritis Rheumatol; 2022 Nov; 74(11):1755-1765. PubMed ID: 35583934
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic, social, and environmental risk factors in rheumatoid arthritis-associated interstitial lung disease.
    Wheeler AM; Baker JF; Poole JA; Ascherman DP; Yang Y; Kerr GS; Reimold A; Kunkel G; Cannon GW; Wysham KD; Singh N; Lazaro D; Monach P; Bridges SL; Mikuls TR; England BR
    Semin Arthritis Rheum; 2022 Dec; 57():152098. PubMed ID: 36155967
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exploration of the MUC5B promoter variant and ILD risk in patients with autoimmune myositis.
    Johnson C; Rosen P; Lloyd T; Horton M; Christopher-Stine L; Oddis CV; Mammen AL; Danoff SK
    Respir Med; 2017 Sep; 130():52-54. PubMed ID: 29206633
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A meta-analysis examining the association between the MUC5B rs35705950 T/G polymorphism and susceptibility to idiopathic pulmonary fibrosis.
    Lee MG; Lee YH
    Inflamm Res; 2015 Jun; 64(6):463-70. PubMed ID: 25926289
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A common MUC5B promoter polymorphism and pulmonary fibrosis.
    Seibold MA; Wise AL; Speer MC; Steele MP; Brown KK; Loyd JE; Fingerlin TE; Zhang W; Gudmundsson G; Groshong SD; Evans CM; Garantziotis S; Adler KB; Dickey BF; du Bois RM; Yang IV; Herron A; Kervitsky D; Talbert JL; Markin C; Park J; Crews AL; Slifer SH; Auerbach S; Roy MG; Lin J; Hennessy CE; Schwarz MI; Schwartz DA
    N Engl J Med; 2011 Apr; 364(16):1503-12. PubMed ID: 21506741
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Presence of T Allele (rs35705950) of the MUC5B Gene Predicts Lower Baseline Forced Vital Capacity and Its Subsequent Decline in Patients with Hypersensitivity Pneumonitis.
    Lewandowska KB; Szturmowicz M; Lechowicz U; Franczuk M; Błasińska K; Falis M; Błaszczyk K; Sobiecka M; Wyrostkiewicz D; Siemion-Szcześniak I; Bartosiewicz M; Radwan-Röhrenschef P; Roży A; Chorostowska-Wynimko J; Tomkowski WZ
    Int J Mol Sci; 2023 Jun; 24(13):. PubMed ID: 37445925
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association between MUC5B polymorphism and susceptibility and severity of idiopathic pulmonary fibrosis.
    Jiang H; Hu Y; Shang L; Li Y; Yang L; Chen Y
    Int J Clin Exp Pathol; 2015; 8(11):14953-8. PubMed ID: 26823827
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of protein-altering variants in telomerase genes and their association with MUC5B common variant status in patients with idiopathic pulmonary fibrosis: a candidate gene sequencing study.
    Dressen A; Abbas AR; Cabanski C; Reeder J; Ramalingam TR; Neighbors M; Bhangale TR; Brauer MJ; Hunkapiller J; Reeder J; Mukhyala K; Cuenco K; Tom J; Cowgill A; Vogel J; Forrest WF; Collard HR; Wolters PJ; Kropski JA; Lancaster LH; Blackwell TS; Arron JR; Yaspan BL
    Lancet Respir Med; 2018 Aug; 6(8):603-614. PubMed ID: 29891356
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.